相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Increased frequency of HLA-A*02 in patients with atherosclerosis is associated with VZV seropositivity
Hamed Fouladseresht et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2021)
Ribavirin and Interferon Therapy for Critically Ill Patients With Middle East Respiratory Syndrome: A Multicenter Observational Study
Yaseen M. Arabi et al.
CLINICAL INFECTIOUS DISEASES (2020)
Immune-Inflammation in Atherosclerosis: A New Twist in an Old Tale
Atefe Ghamar Talepoor et al.
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2020)
Presumed Asymptomatic Carrier Transmission of COVID-19
Yan Bai et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV
Jia Liu et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer
Sufang Tian et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
Peter Richardson et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
Eva Schrezenmeier et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
Timothy P. Sheahan et al.
NATURE COMMUNICATIONS (2020)
Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-The BRACE CORONA Trial
Renato D. Lopes et al.
AMERICAN HEART JOURNAL (2020)
Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report
J. -M. Michot et al.
ANNALS OF ONCOLOGY (2020)
Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
Yvan Jamilloux et al.
AUTOIMMUNITY REVIEWS (2020)
Identification of Human Single-Domain Antibodies against SARS-CoV-2
Yanling Wu et al.
CELL HOST & MICROBE (2020)
Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients
Zhuo Zhou et al.
CELL HOST & MICROBE (2020)
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
Evangelos J. Giamarellos-Bourboulis et al.
CELL HOST & MICROBE (2020)
A Dynamic Immune Response Shapes COVID-19 Progression
Eugenia Ziying Ong et al.
CELL HOST & MICROBE (2020)
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
Shuai Xia et al.
CELL RESEARCH (2020)
Functional exhaustion of antiviral lymphocytes in COVID-19 patients
Meijuan Zheng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients
Hong-Yi Zheng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor
Xiangyu Chen et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System Celebrating the 20th Anniversary of the Discovery of ACE2
Mahmoud Gheblawi et al.
CIRCULATION RESEARCH (2020)
Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis
Brandon Michael Henry et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
Strategies for the prevention and management of coronavirus disease 2019
Wei-jie Guan et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020
Anu Haveri et al.
EUROSURVEILLANCE (2020)
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
Xiaolong Tian et al.
EMERGING MICROBES & INFECTIONS (2020)
Multiomics Evaluation of Gastrointestinal and Other Clinical Characteristics of COVID-19
Mulong Du et al.
GASTROENTEROLOGY (2020)
The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design
Spyridon G. Deftereos et al.
HELLENIC JOURNAL OF CARDIOLOGY (2020)
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Zhe Xu et al.
LANCET RESPIRATORY MEDICINE (2020)
Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19
Hisashi Kai et al.
HYPERTENSION RESEARCH (2020)
Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
Ling Ni et al.
IMMUNITY (2020)
Immunology of COVID-19: Current State of the Science
Nicolas Vabret et al.
IMMUNITY (2020)
The epidemiology, diagnosis and treatment of COVID-19
Pan Zhai et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
Chi Zhang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Type I IFN immunoprofiling in COVID-19 patients
Sophie Trouillet-Assant et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Clinical and immunological features of severe and moderate coronavirus disease 2019
Guang Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
COVID-19 and emerging viral infections: The case for interferon lambda
Ludmila Prokunina-Olsson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Kai Duan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Risk factors associated with disease severity and length of hospital stay in COVID-19 patients
Xiaofan Liu et al.
JOURNAL OF INFECTION (2020)
Diagnostic Performance of CT and Reverse Transcriptase Polymerase Chain Reaction for Coronavirus Disease 2019: A Meta-Analysis
Hyungjin Kim et al.
RADIOLOGY (2020)
Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia
Fan Wang et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
Stephen M. Kissler et al.
SCIENCE (2020)
TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib
Dandan Wu et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2020)
Covid-19: FDA approves use of convalescent plasma to treat critically ill patients
Janice Hopkins Tanne
BMJ-BRITISH MEDICAL JOURNAL (2020)
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
Chaomin Wu et al.
JAMA INTERNAL MEDICINE (2020)
Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
Marc Feldmann et al.
LANCET (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19)
Lei Zha et al.
MEDICAL JOURNAL OF AUSTRALIA (2020)
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
Bo Diao et al.
FRONTIERS IN IMMUNOLOGY (2020)
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Bin Ju et al.
NATURE (2020)
Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing
Wen Wen et al.
CELL DISCOVERY (2020)
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Jia Liu et al.
CELL DISCOVERY (2020)
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
Mingfeng Liao et al.
NATURE MEDICINE (2020)
Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19
Irani Thevarajan et al.
NATURE MEDICINE (2020)
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
Muthiah Vaduganathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia
Stanley C. Jordan et al.
CLINICAL INFECTIOUS DISEASES (2020)
ACE2 at the centre of COVID-19 from paucisymptomatic infections to severe pneumonia
Felice Rivellese et al.
AUTOIMMUNITY REVIEWS (2020)
Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome
Daniela Weiskopf et al.
SCIENCE IMMUNOLOGY (2020)
No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
J. M. Molina et al.
MEDECINE ET MALADIES INFECTIEUSES (2020)
The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities
Louis Maximilian Buja et al.
CARDIOVASCULAR PATHOLOGY (2020)
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients
Nisreen M. A. Okba et al.
EMERGING INFECTIOUS DISEASES (2020)
Anakinra for severe forms of COVID-19: a cohort study
Thomas Huet et al.
LANCET RHEUMATOLOGY (2020)
Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: A retrospective case-control study
Qilin Li et al.
ECLINICALMEDICINE (2020)
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
Giulio Cavalli et al.
LANCET RHEUMATOLOGY (2020)
Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients
Baoqing Sun et al.
EMERGING MICROBES & INFECTIONS (2020)
IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes
Rudragouda Channappanavar et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
MHC Class I Molecules Exacerbate Viral Infection by Disrupting Type I Interferon Signaling
Simo Xia et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2019)
High levels of circulating GM-CSF+CD4+ T cells are predictive of poor outcomes in sepsis patients: a prospective cohort study
Huihuang Huang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
Synthetic surfactant with a recombinant surfactant protein C analogue improves lung function and attenuates inflammation in a model of acute respiratory distress syndrome in adult rabbits
J. Zebialowicz Ahlstrom et al.
RESPIRATORY RESEARCH (2019)
TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer
Alexandre Ivagnes et al.
ONCOIMMUNOLOGY (2018)
Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
Lisa E. Gralinski et al.
MBIO (2018)
Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition
Scott W. Canna et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Human lung natural killer cells are predominantly comprised of highly differentiated hypofunctional CD69-CD56dim cells
Nicole Marquardt et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
Rudragouda Channappanavar et al.
CELL HOST & MICROBE (2016)
Repeated Cycles of Recombinant Human Interleukin 7 in HIV-Infected Patients With Low CD4 T-Cell Reconstitution on Antiretroviral Therapy: Results of 2 Phase II Multicenter Studies
Rodolphe Thiebaut et al.
CLINICAL INFECTIOUS DISEASES (2016)
Immunotherapeutic implications of IL-6 blockade for cytokine storm
Toshio Tanaka et al.
IMMUNOTHERAPY (2016)
Fc receptors in antibody-dependent enhancement of viral infections
Adam Taylor et al.
IMMUNOLOGICAL REVIEWS (2015)
Disease-Promoting Effects of Type I Interferons in Viral, Bacterial, and Coinfections
Sophia Davidson et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2015)
Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome
Jose L. Nieto-Torres et al.
VIROLOGY (2015)
Silencing of CCR2 in myocarditis
Florian Leuschner et al.
EUROPEAN HEART JOURNAL (2015)
Mechanical Ventilation-associated Lung Fibrosis in Acute Respiratory Distress Syndrome A Significant Contributor to Poor Outcome
Nuria E. Cabrera-Benitez et al.
ANESTHESIOLOGY (2014)
Tumor necrosis factor inhibitors - state of knowledge
Krzysztof Lis et al.
ARCHIVES OF MEDICAL SCIENCE (2014)
Subsets of human natural killer cells and their regulatory effects
Binqing Fu et al.
IMMUNOLOGY (2014)
Division of labor between lung dendritic cells and macrophages in the defense against pulmonary infections
M. Guilliams et al.
MUCOSAL IMMUNOLOGY (2013)
Chloroquine Treatment Enhances Regulatory T Cells and Reduces the Severity of Experimental Autoimmune Encephalomyelitis
Rodolfo Thome et al.
PLOS ONE (2013)
Inhibition of novel β coronavirus replication by a combination of interferon- α2b and ribavirin
Darryl Falzarano et al.
SCIENTIFIC REPORTS (2013)
When aging reaches CD4+T-cells: phenotypic and functional changes
Marco Antonio Moro-Garcia et al.
FRONTIERS IN IMMUNOLOGY (2013)
Severe Pandemic H1N1 2009 Infection Is Associated with Transient NK and T Deficiency and Aberrant CD8 Responses
Annette Fox et al.
PLOS ONE (2012)
The T-Cell Response to HIV
Bruce Walker et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases
Nobuhisa Ishikawa et al.
RESPIRATORY INVESTIGATION (2012)
Quelling the storm: utilization of sphingosine-1-phosphate receptor signaling to ameliorate influenza virus-induced cytokine storm
Kevin B. Walsh et al.
IMMUNOLOGIC RESEARCH (2011)
KL-6 concentration in pulmonary epithelial lining fluid is a useful prognostic indicator in patients with acute respiratory distress syndrome
Tomohiro Kondo et al.
RESPIRATORY RESEARCH (2011)
IL-6: Regulator of Treg/Th17 balance
Akihiro Kimura et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Elevated Plasma Surfactant Protein D (SP-D) Levels and a Direct Correlation with Anti-severe Acute Respiratory Syndrome Coronavirus-specific IgG Antibody in SARS Patients
Y. P. Wu et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2009)
Prior Immunization with Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected with SARS-CoV
Fumihiko Yasui et al.
JOURNAL OF IMMUNOLOGY (2008)
T cell responses to whole SARS coronavirus in humans
Chris Ka-fai Li et al.
JOURNAL OF IMMUNOLOGY (2008)
Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome
Mark J. Cameron et al.
JOURNAL OF VIROLOGY (2007)
Inhibitory effect of tumor cell-derived lactic acid on human T cells
Karin Fischer et al.
BLOOD (2007)
The SARS coronavirus spike glycoprotein is selectively recognized by lung surfactant protein D and activates macrophages
Rikke Leth-Larsen et al.
IMMUNOBIOLOGY (2007)
Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia
Elisabeth Kamphuis et al.
BLOOD (2006)
CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs
LR Shiow et al.
NATURE (2006)
Clinical uses of intravenous immunoglobulin
S Jolles et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)
The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis
SB Cohen
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2004)
The inflammasome:: A molecular platform triggering activation of inflammatory caspases and processing of proIL-β
F Martinon et al.
MOLECULAR CELL (2002)
分享论文
